Search

Your search keyword '"Maciel TT"' showing total 56 results

Search Constraints

Start Over You searched for: Author "Maciel TT" Remove constraint Author: "Maciel TT"
56 results on '"Maciel TT"'

Search Results

1. FLT3 inhibitors: clinical potential in acute myeloid leukemia

5. Interactions between eosinophils and IL-5Rα-positive mast cells in nonadvanced systemic mastocytosis.

7. Sputum interleukin-6 level as a marker of severity during acute chest syndrome in children with sickle cell disease.

8. Oral famotidine reduces the plasma level of soluble P-selectin in children with sickle cell disease.

9. Dramatic efficacy of cannabidiol on refractory chronic pain in an adolescent with sickle cell disease.

10. Successful treatment of JAK1-associated inflammatory disease.

11. Sputum IL-6 level as a potential predictor of acute chest syndrome during vaso-occlusive crisis in children with sickle cell disease: Exploratory prospective prognostic accuracy study.

12. Mast cell-mediated inflammation relies on insulin-regulated aminopeptidase controlling cytokine export from the Golgi.

13. Physiological selectivity and tolerance of social wasps exposed to Malathion.

14. HbS promotes TLR4-mediated monocyte activation and proinflammatory cytokine production in sickle cell disease.

16. Neuropilin-1 cooperates with PD-1 in CD8 + T cells predicting outcomes in melanoma patients treated with anti-PD1.

18. Erythrocytosis associated with IgA nephropathy.

19. Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients.

20. Iron-loaded transferrin potentiates erythropoietin effects on erythroblast proliferation and survival: a novel role through transferrin receptors.

22. XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia.

23. A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease.

24. Innate immune cells, major protagonists of sickle cell disease pathophysiology.

25. Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow.

26. Erdheim-Chester Disease: a Concise Review.

27. Plasma histamine elevation in a large cohort of sickle cell disease patients.

28. Pest Control Potential of Social Wasps in Small Farms and Urban Gardens.

29. Innate-like T cells in children with sickle cell disease.

30. Lessons to Learn From Low-Dose Cyclosporin-A: A New Approach for Unexpected Clinical Applications.

31. Serum Iron Protects from Renal Postischemic Injury.

32. High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells.

33. Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis.

34. Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia.

35. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.

36. The role of mast cells in cancers.

37. HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia.

38. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

39. Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.

40. [Regulation of erythropoiesis mediated by immunoglobulin A1].

41. The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia.

42. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors.

43. Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia.

44. Pathologic calcification of adult vascular smooth muscle cells differs on their crest or mesodermal embryonic origin.

45. The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation.

46. Disrupted cell cycle control in cultured endometrial cells from patients with endometriosis harboring the progesterone receptor polymorphism PROGINS.

47. Amitriptyline attenuates interstitial inflammation and ameliorates the progression of renal fibrosis.

48. The bone morphogenetic protein antagonist gremlin promotes vascular smooth muscle cell apoptosis.

49. Endostatin, an antiangiogenic protein, is expressed in the unilateral ureteral obstruction mice model.

50. Gremlin promotes vascular smooth muscle cell proliferation and migration.

Catalog

Books, media, physical & digital resources